Bio-Techne Corp
(TECH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 33,600 | 168,105 | 127,517 | 78,459 | 50,993 |
| Depreciation Amortization | 28,137 | 111,711 | 83,654 | 56,343 | 28,540 |
| Income taxes - deferred | -5,340 | -39,447 | -29,896 | -22,314 | -11,591 |
| Accounts receivable | 21,563 | -20,533 | -2,611 | 20,333 | 15,599 |
| Accounts payable and accrued liabilities | -10,911 | 25,769 | 7,160 | 5,382 | -2,695 |
| Other Working Capital | -9,737 | -10,106 | 130 | -1,201 | -19,977 |
| Other Operating Activity | 6,577 | 63,482 | 37,531 | 5,497 | -1,486 |
| Operating Cash Flow | $63,889 | $298,981 | $223,485 | $142,499 | $59,383 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,085 | 22,557 | 18,233 | 18,233 | 23,759 |
| PPE Investments | -9,172 | -62,877 | -44,897 | -28,456 | -13,592 |
| Net Acquisitions | N/A | -169,707 | -169,707 | -169,707 | -166,426 |
| Purchase Of Investment | -15,000 | N/A | 0 | 0 | 0 |
| Other Investing Activity | 1,403 | 6,997 | 2,149 | 2,149 | 2,149 |
| Investing Cash Flow | $-21,684 | $-203,030 | $-194,222 | $-177,781 | $-154,110 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 225,000 | 225,000 | 225,000 | 160,000 |
| Debt Repayment | -19,000 | -256,000 | -186,000 | -128,000 | -70,000 |
| Common Stock Issued | 25,101 | 60,935 | 38,001 | 19,670 | 14,394 |
| Common Stock Repurchased | N/A | -80,042 | -80,042 | -80,042 | N/A |
| Dividend Paid | -12,688 | -50,419 | -37,792 | -25,213 | -12,654 |
| Other Financing Activity | -4,984 | -21,872 | -21,470 | -21,302 | -20,228 |
| Financing Cash Flow | $-11,571 | $-122,398 | $-62,303 | $-9,887 | $71,512 |
| Exchange Rate Effect | 5,115 | -2,333 | -7,616 | -5,270 | -8,693 |
| Beginning Cash Position | 151,791 | 180,571 | 180,571 | 180,571 | 180,571 |
| End Cash Position | 187,540 | 151,791 | 139,915 | 130,132 | 148,663 |
| Net Cash Flow | $35,749 | $-28,780 | $-40,656 | $-50,439 | $-31,908 |
| Free Cash Flow | |||||
| Operating Cash Flow | 63,889 | 298,981 | 223,485 | 142,499 | 59,383 |
| Capital Expenditure | -9,172 | -62,877 | -44,897 | -28,456 | -13,592 |
| Free Cash Flow | 54,717 | 236,104 | 178,588 | 114,043 | 45,791 |